In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vivacta Ltd.

Division of Novartis AG
www.vivacta.com

Latest From Vivacta Ltd.

Device/Diagnostics Quarterly Deal Statistics, Q4 2012

Device firms closed the final quarter of 2012 with $1.1 billion in financing, led by Volcano’s debt offering. Takeovers of Gambro and PSS Medical topped the device M&A list. At $196 million, Q4 diagnostic financing was the lowest quarter of the year, but IPOs returned with three public debuts. Amgen’s $415 million acquisition of deCODE was the largest diagnostic M&A.

Medical Device Deals

Medical Device Deals Update, January 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, Alliance, and Financing activity.

Medical Device

Deals Shaping The Medical Industry, January 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Pharmaceuticals, and Medical Devices – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Deals Update (01/2008)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Biosensors
    • Chemistry, Immunoassay
    • Therapeutic Drug Monitoring
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • PanOpsys Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • Tim Carter, PhD, CEO
    Nigel Newton, Fin. Dir.
    Oliver Boucher, Chief Bus. Officer
    Steve Ross, Dir., R&D
  • Contact Info
  • Vivacta Ltd.
    Phone: (44) (0)1795 419400
    100 Guillat Av.
    Kent Science Pk
    Sittingbourne, Kent, ME9 8GU
    UK
UsernamePublicRestriction

Register